William Lis is Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 53,521 shares of JSPR, which is worth approximately $1.15 Million. The most recent transaction as insider was on Oct 13, 2023, when has been sold 7,965 shares (Voting Common Stock) at a price of $0.85 per share, resulting in proceeds of $6,770. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.5K
0% 3M change
0% 12M change
Total Value Held $1.15 Million

William Lis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 13 2023
SELL
Open market or private sale
$6,770 $0.85 p/Share
7,965 Reduced 12.95%
53,521 Voting Common Stock
Apr 13 2023
SELL
Open market or private sale
$12,240 $1.44 p/Share
8,500 Reduced 12.15%
61,486 Voting Common Stock
Oct 12 2022
BUY
Grant, award, or other acquisition
-
29,500 Added 29.65%
69,986 Voting Common Stock
Jun 27 2022
SELL
Open market or private sale
$51,465 $2.08 p/Share
24,743 Reduced 37.93%
40,486 Voting Common Stock
Jun 24 2022
SELL
Open market or private sale
$49,981 $2.02 p/Share
24,743 Reduced 27.5%
65,229 Voting Common Stock
Mar 21 2022
BUY
Grant, award, or other acquisition
-
89,972 Added 50.0%
89,972 Voting Common Stock

Also insider at

ZLAB
Zai Lab Ltd Healthcare
EIDX
Eidos Therapeutics, Inc.
WL

William Lis

Director
Pudong, Shanghai, F4

Track Institutional and Insider Activities on JSPR

Follow Jasper Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

News

Receive news related to Jasper Therapeutics, Inc.

Track Activities on JSPR